ERBB2 and B-cell non-Hodgkin lymphoma: For example, Trastuzumab deruxtecan is an anti-ERBB2 antibody conjugated with topoisomerase inhibitor for NSCLC with HER2 mutation [190] and an anti-CD20 antibody conjugated with a nanoparticle loaded with paclitaxel for B-cell lymphoma [191].